Bio-Rad Laboratories (BIO)
Bio-Rad Laboratories Interest Expense: 13.20M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
BIO Interest Expense Rankings
| Overall | 17th percentile | 3825 of 4657 |
| Sector | 7th percentile | 801 of 868 in Technology |
| Industry | 3rd percentile | 54 of 56 in Scientific & Technical Instruments |
BIO Interest Expense Range, Past 5 Years
| Minimum | 7.807M | Mar 2009 |
| Maximum | 20.55M | Dec 2010 |
| Average | 11.65M |
About Interest Expense
When companies borrow money to expand or maintain their business operations, they must pay interest on the money that they borrow. The interest expense is the annual accrued amount of interest that the company paid (or sometimes will have to pay) to its creditors.
YCharts includes both operating interest expense and non-operating interest expense in our numbers.
Learn More
You may also be interested in these BIO related companies
BIO News
Bio-Rad Named One of the '2012 Best Places to Work' in the San Francisco Bay Area
May 15, 1:22PM Marketwire
May 15, 1:22PM Marketwire
Dougherty & Co Downgrades Bio-Rad Labs (BIO) to Neutral; Slow Start to '12, Margin Pressure Could Continue in '13
May 02, 8:42AM Street Insider
May 02, 8:42AM Street Insider
UPDATE: Jefferies Increases PT to $125 on Bio-Rad Laboratories; Improved Profitability
May 02, 8:05AM Benzinga
May 02, 8:05AM Benzinga
Bio-Rad Laboratories' CEO Discusses Q1 2012 Results - Earnings Call Transcript
May 01, 10:15PM Seeking Alpha
May 01, 10:15PM Seeking Alpha
Listen to $BIO Q1 2012 earnings call - live at 05:00 PM, ondemand after - http://stks.co/3c15
about 26 days ago by earningscast
about 26 days ago by earningscast
$HBIO to present at SeeThruEquity Small Inv Conf 6/5, Cornell Club in NYC http://stks.co/3P4h $ABT $BDX $TMO $BIO $MR $COV
about 39 days ago by ATandon_STE
about 39 days ago by ATandon_STE
Bio-Rad to Report First-Quarter 2012 Financial Results Tuesday, May 1, 2012
Apr 10, 7:22PM Marketwire
Apr 10, 7:22PM Marketwire
11 breakouts: $BIO, $CSU, $IPHS, $SZYM (gap). One $1-2 stock no sub-$1. Not a whole lot of action on the movers and shakers but no pennies
about 54 days ago by fallondpicks
about 54 days ago by fallondpicks
$BIO just thinking outloud here. Is there takeover speculation after a cofounder's passing?
about 54 days ago by tickertutor
about 54 days ago by tickertutor
Bio-Rad Laboratories, SmartHeat: Biggest Price Gainers (BIO, HEAT)
Apr 03, 12:54PM The Wall Street Journal
Apr 03, 12:54PM The Wall Street Journal
$BIO is 5.7% up since open on unusual high volume and 5.9% up since close.
about 55 days ago by TradeBot
about 55 days ago by TradeBot
Luminex (LMNX), Bio-Rad (BIO) Enter MAGPIX Sales, Distribution Agreement
Apr 03, 6:41AM Street Insider
Apr 03, 6:41AM Street Insider
Luminex and Bio-Rad Extend Their Global Sales and Distribution Agreement to 2023
Apr 03, 5:30AM PR Newswire
Apr 03, 5:30AM PR Newswire
David Schwartz, Bio-Rad Co-Founder and Chairman of the Board, Passes Away at 88
Apr 02, 7:58PM Marketwire
Apr 02, 7:58PM Marketwire
$BIO forms bullish "Ascending Continuation Triangle" chart pattern. http://stks.co/2x6H
about 69 days ago by RecogniaEvents
about 69 days ago by RecogniaEvents
Bio-Rad Laboratories' CEO Discusses Q4 2011 Results - Earnings Call Transcript
Feb 23, 11:29PM Seeking Alpha
Feb 23, 11:29PM Seeking Alpha
Listen to $BIO Q4 2011 earnings call - live at 05:00 PM, ondemand after - http://stks.co/2XSc
about 94 days ago by earningscast
about 94 days ago by earningscast
$BIO Reports Q4 Prelim EPS $2.08 vs $1.67 Est; Revenues $550.2M vs $562.06M Est
about 94 days ago by Benzinga
about 94 days ago by Benzinga
$BIO http://stks.co/265s Enters low volume area w/no significant resistance, run to 115 seems attainable. Notes on chart.
about 123 days ago by redman59
about 123 days ago by redman59
Monthly. What the fork is going on here. RoC looks to be bottoming, prior reading a good entry spot. $BIO http://chart.ly/ebn93k5
about 163 days ago by 1nvestor
about 163 days ago by 1nvestor
$BIO Bio-Rad Labatories Reports Q3 EPS $1.61 vs $1.53 Est; Revenues $516.5M vs $511.47M Est
about 208 days ago by Benzinga
about 208 days ago by Benzinga
$BIO http://chart.ly/35pt3kh Weekly. Starting to smell the brakes on the decline here. Stalking for a hold abv 100.
about 289 days ago by 1nvestor
about 289 days ago by 1nvestor
$BIO
Bio-Rad Labs Reports Q2 EPS $1.41 vs $1.47 Est; Revenues $521.7M vs $508.17M Est
about 299 days ago by Benzinga
about 299 days ago by Benzinga
I like $BIO on Fundamentals, Technicals, and because Noone else is watching it....until now :)
about 420 days ago by OptionRadar
about 420 days ago by OptionRadar
$BIO reports $2.41 per share, $1.06 better than est. revenues $533.7 mln vs the $514.5 mln est.
about 458 days ago by Benzinga
about 458 days ago by Benzinga
$BIO http://chart.ly/jp8b73a Batteries charged. Getting ready for another run.
about 503 days ago by vjtweet
about 503 days ago by vjtweet
RT @grandmadollar: #HeavyweightStocks - $AZO Hold Long 257.8; $NFLX Long 199; $FCX Flat 101; $BIO Flat 94; $BIDU Flat 107; $FSLR Hold Sh ...
about 544 days ago by maxrobespierre
about 544 days ago by maxrobespierre
RT @grandmadollar: #HeavyweightStocks - $AZO Hold Long 251; $NFLX Flat 173; $FCX Flat 102; $BIO Flat 96; $BIDU Flat 108; $FSLR Short 127
about 554 days ago by maxrobespierre
about 554 days ago by maxrobespierre
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| BIO | 101.39 | -0.63 | -0.62% | 2.859B |
| BIN | 19.71 | -0.18 | -0.91% | 2.312B |
| BIK | 20.72 | -0.02 | -0.10% | |
| BIIB | 131.56 | -0.09 | -0.07% | 31.41B |
| BIG | 37.30 | +1.55 | +4.34% | 2.469B |
| BIF | 5.73 | +0.01 | +0.17% | |
| BIDZ | 0.76 | +0.01 | +0.66% | 13.97M |
| BDN | 11.29 | -0.07 | -0.62% | 1.611B |
| BDMS | 16.95 | -0.04 | -0.23% | 31.19M |
| BDL | 7.30 | +0.11 | +1.53% | 13.58M |
